|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/192 | |
| A61P 17/02 |
| (11) | Patento numeris | 1744739 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05735648.7 |
| Europos patento paraiškos padavimo data | 2005-04-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-01-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2010-03-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/012471 |
| Data | 2005-04-12 |
| (87) | Numeris | WO 2005/099680 |
| Data | 2005-10-27 |
| (30) | Numeris | Data | Šalis |
| 561157 P | 2004-04-12 | US |
| (72) |
WADE, Michael, US
JEFFS, Roger, Andrew, US
STROOTMAN, Deborah, US
|
| (73) |
United Therapeutics Corporation,
1040 Spring Street Silver Spring, Maryland 20910,
US
|
| (54) | USE OF TREPROSTINIL TO TREAT NEUROPATHIC DIABETIC FOOT ULCERS |
| USE OF TREPROSTINIL TO TREAT NEUROPATHIC DIABETIC FOOT ULCERS |